Success Stories: EB-1A Petition Approved for Highly Cited Expert in Health Economics and Pharmacoeconomics

Client’s Testimonial:

“Thank you so much for sending the approval notice for my EB1A case. It has been a pleasure working with you throughout this process, and I truly appreciate your support.”

On June 3^rd, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Scholar in the Field of Health Outcomes Research and Pharmacoeconomics (Approval Notice).

General Field: Health Outcomes Research and Pharmacoeconomics

Position at the Time of Case Filing: Postdoctoral Scholar

Country of Origin: Ethiopia

State of Residence at the Time of Filing: Ohio

Approval Notice Date: June 3^rd, 2025

Processing Time: 7 months, 17 days (Premium Processing Requested)

Case Summary:

Our client has earned international recognition for his pioneering work at the intersection of epidemiology, health economics, and pharmacoeconomics. His research has advanced understanding in areas such as cardiovascular disease outcomes, chronic disease treatment effectiveness, and medication adherence, fields vital to improving global and national public health.

He has made original contributions of major significance, including:

o Conducting comprehensive evaluations of hypertension and cardiovascular outcomes,

o Investigating patient safety in low-income countries, and

o Exploring clinical outcomes in mental health disorders.

His research addresses some of the world’s most urgent healthcare challenges, such as predicting uncontrolled diabetes outcomes, assessing treatment effectiveness for chronic conditions, and improving quality of life for patients facing long-term illness.

In fact, our client is among the top 1% most highly cited authors publishing in medicine over the past eight years. His research has been cited 2307 times, and he holds an h-index of 24, placing him in the top 2% of medical researchers worldwide. This level of citation not only reflects academic prestige, but it also underscores the broad, practical impact of his work.

“It is clear that [client] stands at the top of his field, given his achievements in areas such as conducting comprehensive meta-analyses to evaluate antihypertensive medication adherence, assessing organ damage due to uncontrolled hypertension, and investigating the safety and effectiveness of antihypertensive drugs. Ensuring the continuation of [client]’s work is thus deeply important to both health outcomes research and pharmacoeconomics and the nation.”

Our client’s leadership extends beyond publication. He has:

● Authored 41 peer-reviewed journal articles (15 first-authored),

● Published 10 abstracts (8 first-authored), and

● Contributed 2 preprints, further disseminating knowledge to the research community.

In service to the field, he has also completed at least 20 peer reviews and served as both a guest editor and handling editor for respected academic journals.

Recognizing the exceptional nature of his career, the North America Immigration Law Group (NAILG) prepared and submitted our client’s EB-1A petition. By demonstrating his original contributions, leadership roles, and field-wide impact, NAILG successfully secured approval, affirming his standing as an individual of extraordinary ability.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.